Acquisition · Portfolio-company
Pharmachem / Ashland nutraceuticals
Transaction overview
Status: Reported completed
Exact closing date not established.
Turnspire backed the acquisition of Ashland’s nutraceuticals business, subsequently known as Pharmachem. The agreement was announced in May 2024 and completion reported in September 2024. The exact closing date is not established.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business ↗
Turnspire Capital Partners · Published May 7, 2024
Supports transaction chronology and scope; exact closing date is not established.
- Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland ↗
Turnspire Capital Partners · Published Sep 3, 2024
Supports transaction chronology and scope; exact closing date is not established.